By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


La Jolla Pharmaceutical Company 

6455 Nancy Ridge Drive

San Diego  California  92121  U.S.A.
Phone: 858-452-6600 Fax: 858-452-6893



Company News
La Jolla Pharma (LJPC) Announces Notice Of Allowance For U.S. Patent Covering LJPC-501 11/30/2015 10:39:55 AM
La Jolla Pharma (LJPC) Announces Third Quarter 2015 Financial Results And Recent Corporate Progress 11/6/2015 11:52:56 AM
La Jolla Pharma (LJPC) Doses First Patient In Phase I Clinical Trial Of LJPC-401 In Patients At Risk Of Iron Overload 10/19/2015 10:49:22 AM
La Jolla Pharma (LJPC) Closes Offering Of Common Stock 9/16/2015 12:15:46 PM
La Jolla Pharma (LJPC) Receives Positive Opinion From European Orphan Committee For LJPC-401 9/11/2015 7:35:31 AM
La Jolla Pharma (LJPC) Announces Proposed Underwritten Offering Of Common Stock 9/10/2015 12:21:53 PM
La Jolla Pharma (LJPC) Announces Pricing Of Underwritten Offering Of Common Stock 9/10/2015 10:36:03 AM
La Jolla Pharma (LJPC) Receives Orphan Drug Designation For Two Novel Compounds For Fibrodysplasia Ossificans Progressiva 8/18/2015 10:20:25 AM
La Jolla Pharma (LJPC) And Vanderbilt University Enter Exclusive Research And License Agreement Covering Novel BMP Type-I Receptor Inhibitors 8/18/2015 9:55:28 AM
La Jolla Pharma (LJPC) Announces FDA Acceptance Of IND For LJPC-401 8/11/2015 10:38:35 AM